search
MDMA
Trends
- 1Age may explain conflicting psychedelic study results▼Could age help explain why psychedelic studies reach different conclusions?
Researchers suggest participants' age could account for why psychedelic studies produce differing conclusions about safety and effectiveness. Older adults may respond differently to substances like psilocybin or MDMA, meaning trials skewed toward younger or older volunteers could reach inconsistent findings. The claim highlights a gap in how psychedelic research is designed and interpreted.
- 2Psychedelic Drugs Market Set to Grow Through 2035●Psychedelic Drugs Market Forecast to 2035: Demand Accelerates on Mental Health Crisis and Regulatory Breakthroughs
A new market forecast projects the psychedelic drugs market to expand through 2035, driven by rising demand for mental health treatments and regulatory breakthroughs in approving psychedelic-based therapies. Industry analysts say growing acceptance of substances like psilocybin and MDMA for conditions such as depression and PTSD is attracting investment, though clinical and legal hurdles remain ahead of widespread adoption.
- 3High-dose MDMA pill circulating in Lucerne, Switzerland●[Bitcoin] MDMA (145mg); MDEA* (0.7mg); Unknown – Luzern, Switzerland – 2026-08-28 Detected: MDMA (145mg); MDEA* (0.7mg);
Drug-checking services in Lucerne, Switzerland, flagged a white pill stamped with a Bitcoin logo, weighing 528 mg, that was found to contain 145 mg of MDMA plus a small amount of MDEA and an unidentified substance. Public warnings like this alert users that the pill contains a notably high dose of MDMA, raising risk of overdose, especially as the extra components are unconfirmed.